Document Detail


The AP-1 transcription factor Fra1 inhibits follicular B cell differentiation into plasma cells.
MedLine Citation:
PMID:  25288397     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The cornerstone of humoral immunity is the differentiation of B cells into antibody-secreting plasma cells. This process is tightly controlled by a regulatory gene network centered on the transcriptional repressor B lymphocyte-induced maturation protein 1 (Blimp1). Proliferation of activated B cells is required to foster Blimp1 expression but needs to be terminated to avoid overshooting immune reactions. Activator protein 1 (AP-1) transcription factors become quickly up-regulated upon B cell activation. We demonstrate that Fra1, a Fos member of AP-1, enhances activation-induced cell death upon induction in activated B cells. Moreover, mice with B cell-specific deletion of Fra1 show enhanced plasma cell differentiation and exacerbated antibody responses. In contrast, transgenic overexpression of Fra1 blocks plasma cell differentiation and immunoglobulin production, which cannot be rescued by Bcl2. On the molecular level, Fra1 represses Blimp1 expression and interferes with binding of the activating AP-1 member c-Fos to the Blimp1 promoter. Conversely, overexpression of c-Fos in Fra1 transgenic B cells releases Blimp1 repression. As Fra1 lacks transcriptional transactivation domains, we propose that Fra1 inhibits Blimp1 expression and negatively controls plasma cell differentiation through binding to the Blimp1 promoter. In summary, we demonstrate that Fra1 negatively controls plasma cell differentiation by repressing Blimp1 expression.
Authors:
Bettina Grötsch; Sebastian Brachs; Christiane Lang; Julia Luther; Anja Derer; Ursula Schlötzer-Schrehardt; Aline Bozec; Simon Fillatreau; Ingolf Berberich; Elias Hobeika; Michael Reth; Erwin F Wagner; Georg Schett; Dirk Mielenz; Jean-Pierre David
Related Documents :
25446637 - The search for plants with anticancer activity: pitfalls at the early stages.
25329167 - Quantitative analysis of cytokinesis in situ during c. elegans postembryonic development.
21512417 - Inhibition of task-3 (kcnk9) channel biosynthesis changes cell morphology and decreases...
25320307 - Merkel cell polyomavirus small t antigen mediates microtubule destabilisation to promot...
16337157 - The role of camkii in bdnf-mediated neuroprotection of retinal ganglion cells (rgc-5).
18203057 - Berberine inhibits growth of the breast cancer cell lines mcf-7 and mda-mb-231.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-10-6
Journal Detail:
Title:  The Journal of experimental medicine     Volume:  -     ISSN:  1540-9538     ISO Abbreviation:  J. Exp. Med.     Publication Date:  2014 Oct 
Date Detail:
Created Date:  2014-10-7     Completed Date:  -     Revised Date:  2014-10-8    
Medline Journal Info:
Nlm Unique ID:  2985109R     Medline TA:  J Exp Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2014 Grötsch et al.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Myeloproliferative neoplasms can be initiated from a single hematopoietic stem cell expressing JAK2-...
Next Document:  The miR-155-PU.1 axis acts on Pax5 to enable efficient terminal B cell differentiation.